By the FormBlends Editorial Team. Medically reviewed by Dr. Sarah Chen, MD.
Last March, a woman named Dana in Phoenix spent eleven hours on a Saturday comparing tirzepatide providers. She had a spreadsheet open with fourteen tabs. She told us she'd screenshotted pricing pages from six different platforms, only to find that three of them had changed their numbers by Monday morning. "I kept thinking I was close to a decision, and then I'd find another fee buried in the FAQ," she said. Her final all-in cost estimate for 12 months ranged from $2,400 to $6,800 depending on the provider, the dose trajectory, and whether the consultation fees were actually included or tacked on separately. Dana is not unusual. She's the norm.
That confusion is why this hub exists. Not to crown a winner, but to lay the actual differences on the table so you can stop toggling between browser tabs at midnight.
Here's the thing: marketing copy across these platforms is nearly interchangeable. They all say "physician-supervised." They all say "convenient." They all promise some version of personalized care. The meaningful differences are structural, and they hide in the places most people don't think to look until they're already enrolled.
A note on our position: FormBlends sells compounded tirzepatide. We are not pretending to be neutral observers. What we can do is tell you exactly how our offering stacks up against the competition and let you decide. Several of the platforms below also sell semaglutide, oral meds, or non-GLP-1 metabolic products, but this guide is scoped to their tirzepatide offerings only.
For the clinical deep-dive on the molecule itself, see the Compounded Tirzepatide Complete Guide.
Important: Compounded tirzepatide is not FDA-approved. FormBlends is not a medical practice and does not prescribe medication.
Three Business Models, Three Very Different Experiences
Not all tirzepatide telehealth looks the same under the hood. The market has shaken out into three distinct lanes.
Brand-first platforms. Hims, Ro, and a handful of others launched their tirzepatide programs around the FDA-approved branded drug Zepbound, working through manufacturer channels like LillyDirect with insurance and cash-pay options. Some have since grafted on a compounded product as the budget lane. Compounded availability on these platforms shifts often (sometimes week to week), and pricing structures can be opaque.
Compounded-first telehealth. This is where the bulk of the market sits. Henry Meds, Mochi Health, Eden, Ivim Health, ShedRx, Skinny Rx, Lavender Sky Health, and Medvi all built their core business around cash-pay compounded GLP-1s. Monthly all-in pricing generally ranges from about $199 to $499 for tirzepatide, but "all-in" means different things to different companies. Dose, plan length, and bundled services create wide variance.
Concierge and bundled models. The higher-touch end of the spectrum wraps medication with coaching, lab monitoring, dietitian support, and actual ongoing clinician relationships. Monthly fees run $300 to $700. Mochi Health and Lavender Sky Health lean toward this tier; others offer it as an upsell.
Which model fits you depends on what problem you're actually solving. Cheap refills at a stable dose? Different answer than a first-time patient who wants someone watching the dose escalation closely.
The Details That Actually Separate These Providers
Where the medication comes from
This is the single most underappreciated variable.
A 503A pharmacy is a state-licensed compounder filling individual prescriptions. A 503B facility is FDA-registered as an outsourcing facility and produces larger batches under stricter cGMP-style quality controls. Both can legally dispense compounded tirzepatide where state rules allow, but the oversight gap between the two is real.
Most compounded-first platforms work with 503A partners. Some name those partners publicly. Some don't. A few work with 503B outsourcing facilities, which tends to raise wholesale costs but also raises the quality floor.
When you're evaluating a provider's site, look for three things: a named pharmacy partner, verifiable state licensure, and certificates of analysis covering sterility, potency, and endotoxins. If none of those are findable, that tells you something.
How much doctor you actually get
"Physician-supervised" is doing a lot of heavy lifting in this market. On some platforms, it means a licensed clinician reviews your asynchronous questionnaire and writes a prescription without ever hearing your voice. On others, it means a scheduled video visit. The clinical literature is mixed on which model produces better outcomes for GLP-1 prescribing in otherwise healthy adults. For patients with comorbidities (type 2 diabetes, cardiovascular history, prior eating disorders), more clinician contact is the safer bet. Full stop.
A useful heuristic: if a platform approves your tirzepatide prescription in under ten minutes with zero follow-up questions about your medical history, treat that as a red flag regardless of how polished the website looks.
The price you'll actually pay
My least favorite trend in this market is the "starting at" game. A provider quotes $199/month on the landing page, but that number doesn't include the initial consultation ($49 to $99), the dose escalation surcharge that kicks in at month three, or the multi-month prepayment lock-in.
The only number worth comparing across providers is the all-in 12-month cost at your expected maintenance dose. That means asking four specific questions before you sign up:
- What does month one cost, including the consult?
- What does month three or four cost when I move to 5 mg or 7.5 mg?
- Is there a multi-month prepayment requirement?
- What happens if I want to cancel or pause?
Dose escalation pace
Some platforms ship monthly. Some ship every 12 weeks. Some auto-escalate your dose without a check-in; others require clinician sign-off at each step. Faster escalation is not better, especially given the GI side effects that hit hardest in the first weeks at a new dose. But being stuck at 2.5 mg for months because the platform's scheduling system is backlogged is its own kind of problem.
Your state, their license
Telehealth prescribing requires the clinician to hold a license in the patient's state. Not every platform covers every state. California, Florida, Mississippi, and Louisiana have had additional regulatory wrinkles at various points. Some compounded providers simply don't ship to certain states. Verify coverage before entering your credit card number, not after.
Regulatory track record
Several large telehealth weight-loss platforms received FDA warning letters in 2023, 2024, and 2025 covering marketing claims, misbranding, and adverse event reporting. Getting a warning letter doesn't automatically mean a platform is unsafe. It does mean the FDA found something worth flagging. We note public warning letter history in the individual reviews where relevant.
Provider-by-Provider Reviews
Each link below leads to a detailed review of one platform's tirzepatide offering, covering pricing, sourcing, clinical model, state coverage, refill policies, what's bundled, and any public regulatory history.
Not sure which GLP-1 is right for you?
Take a 2-minute assessment and get a personalized recommendation after licensed provider review.
Take the Assessment →- Hims Tirzepatide Review: Is Hims Legit for Compounded Tirzepatide?
- Henry Meds Tirzepatide Review: Pricing, Sourcing, and Doctor Model
- Mochi Health Tirzepatide Review: What to Know Before Signing Up
- Henry Meds vs Hims for Tirzepatide: Side-by-Side Comparison
- Eden Tirzepatide Review: Pricing, Pharmacies, and Provider Model
- Lavender Sky Health Tirzepatide Review
- Ivim Health Tirzepatide Review
- ShedRx Tirzepatide Review
- Skinny Rx Tirzepatide Review
- Medvi Tirzepatide Review: Is Medvi Legit?
Quick Comparison Snapshot
The table below is a high-level orientation. Pricing on every platform shifts frequently (sometimes mid-month). The individual reviews are updated more often; treat this table as a starting point, not gospel.
| Provider | Starting Monthly | Clinical Model | Public Pharmacy Partner | Concierge Tier | | --- | --- | --- | --- | --- | | Hims | Around $199 starter, then variable | Async + clinician review | Multiple, not always disclosed | No | | Henry Meds | Around $297 to $399 | Sync video or async + review | Various 503A | No | | Mochi Health | Around $79 visit fee plus medication | Sync + coaching | Various | Yes, included | | Eden | Around $296 to $400 | Async + clinician review | Various 503A | No | | Lavender Sky Health | Around $349 to $499 | Sync + clinician + dietitian | Named 503A pharmacies | Yes | | Ivim Health | Around $199 to $399 | Sync + clinician | Named pharmacy partners | Optional add-ons | | ShedRx | Around $189 to $299 | Async + clinician review | Various 503A | No | | Skinny Rx | Around $249 to $349 | Async + clinician review | Various 503A | No | | Medvi | Around $199 to $349 | Async + clinician review | Various 503A | No | | FormBlends | All-in transparent pricing, no auto-escalation upcharges | Sync clinician review + ongoing access | Named licensed U.S. pharmacies | Available |
Numbers reflect early 2026 published pricing. Confirm on each provider's site before enrolling.
Where FormBlends Sits in This Lineup
We are not the cheapest option. We won't pretend otherwise.
What FormBlends does: holds the all-in price flat through dose escalation (no surprise surcharges at 5 mg), names the dispensing pharmacy, and provides certificates of analysis on request. The clinical model is synchronous review with named clinicians. We don't run questionnaire-only approvals.
Whether that trade-off is worth it depends entirely on what you need. Someone who's been on stable-dose tirzepatide for six months and just wants affordable refills is solving a different problem than someone starting therapy for the first time who wants a clinician actually watching the ramp-up. Comparing telehealth providers is a bit like comparing airlines: the seat gets you to the same destination, but the experience at 30,000 feet varies wildly, and the ticket price alone doesn't tell you which one you'll regret booking.
The individual reviews in this cluster are written to help with that decision honestly, not to funnel everyone toward us.
Frequently Asked Questions
1. Is compounded tirzepatide legal in 2026?
Yes, when dispensed by a licensed compounding pharmacy under a valid prescription. The FDA's official shortage status for tirzepatide ended in late 2024. Compounded tirzepatide continues to be dispensed under the standing personalization and individualization provisions of 503A and 503B pharmacy law, with state-by-state nuance in how those provisions are interpreted.
2. Which tirzepatide telehealth provider has the cheapest first month?
Headline starter pricing as of early 2026 sits in the $189 to $249 range across Hims, ShedRx, Eden, Medvi, and a few others. But first-month pricing is a misleading comparison metric. Always run the 12-month all-in number at your expected maintenance dose.
3. Are the 503A pharmacies used by telehealth providers safe?
503A pharmacies are state-licensed and inspected, but the FDA does not pre-review compounded products for safety, potency, or sterility. Quality varies pharmacy to pharmacy. Named partners with current state licensure and third-party batch testing represent the lower-risk option.
4. Has any tirzepatide telehealth provider gotten an FDA warning letter?
Several large telehealth weight-loss platforms have received FDA warning letters in recent years covering marketing claims and misbranding. Specifics are covered in the individual provider reviews where applicable.
5. What is the difference between Hims tirzepatide and Henry Meds tirzepatide?
Hims sells both branded Zepbound (with insurance options) and compounded tirzepatide via partner pharmacies, using a brand-forward async model. Henry Meds sells compounded only, with a higher-touch synchronous clinical model. The side-by-side comparison article in this cluster covers the differences in detail.
6. Does any platform include doctor visits and coaching in the monthly price?
Yes. Mochi Health and Lavender Sky Health bundle coaching and dietitian access. Ivim Health offers similar add-ons. Henry Meds includes clinician access but not formal coaching. Most async-only platforms do not include coaching.
7. What if my provider stops shipping tirzepatide?
It has happened. A few telehealth platforms paused or modified compounded tirzepatide offerings after the FDA shortage status changed. If your provider stops, you can transfer your prescription to another licensed compounding pharmacy through a new telehealth provider or your local prescriber. Plan for transition risk by keeping a small buffer supply when possible.
8. Is Medvi legit?
Medvi is a licensed telehealth platform with prescribing clinicians and compounding pharmacy partners. The detailed review covers the specifics. "Legit" in the regulatory sense? Yes. Whether it's the right clinical fit depends on your situation and what level of oversight you want.
9. What about Lavender Sky Health and Ivim Health?
Both are higher-touch platforms that include meaningful clinician interaction and ancillary services like dietitian access. Pricing is correspondingly higher than the lean async-only platforms. Detailed reviews are linked above.
10. Should I just get tirzepatide from my regular doctor?
If your PCP or endocrinologist will prescribe compounded tirzepatide and you have a compounding pharmacy you trust, that is often the most cost-effective and clinically sound path. The catch is that most PCPs don't write compounded GLP-1 prescriptions, which is the entire reason the telehealth market exists.
---
Disclaimer: This article is for informational purposes only and is not medical advice. Compounded tirzepatide is not FDA-approved. FormBlends is not a medical practice and does not prescribe medication. Always verify provider claims independently and consult a licensed clinician before starting any medication.
Return to the Compounded Tirzepatide Complete Guide.